BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright ©The Author(s) 2026.
World J Clin Cases. Jan 16, 2026; 14(2): 114762
Published online Jan 16, 2026. doi: 10.12998/wjcc.v14.i2.114762
Table 1 Full hemogram findings
Parameter
Units
Results
Reference range
WBC× 109/L4.694.0-10.8
Neutrophils%32.840-75
Lymphocytes%59.921-40
Monocytes%5.43-12
Eosinophils %1.40.5-5
Basophils %0.50.5-5
RBC× 109/L4.564.7-6.1
HBg/dL12.611.2-16.0
HCT%38.337.0-47.0
MCVfL83.976.0-100.0
MCHPg27.527.0-31.0
MCHCg/dL32.832.0-36.0
RDW-C%13.811.5-14.5
Platelets count× 109/L202160.0-450.0
MPVfL9.16.5-12.0
PDW%15.99.0-17.0
PCT%0.2280.108-0.282
Table 2 Liver function test findings
Parameter
Units
Results
Reference range
Albuming/L36.3335-52
ALPU/L38.135-104
ALTU/L34.20-40
ASTU/L33.90-32
GGTU/L6.75-36
Total proteing/L68.466-87
Table 3 Urea, creatinine, and electrolytes findings
Parameter
Units
Results
Reference range
Chloride mmol/L101.595-107
Creatinine µmol/L6844-80
Potassiummmol/L3.863.5-5.1
Sodiummmol/L135.7135-145
Ureammol/L4.642.76-8.07
Table 4 C-reactive protein findings
Parameter
Units
Results
Reference range
CRPmg/L75.20-10.0
Table 5 Literature review
Ref.
Country
Trimester
Management
Maternal outcome
Fetal outcome
Najafian et al[2], 2020IranAllAntivenom administered 6-12 hours post-sting; supportive careStable11% neonatal complications; Apgar < 8 in 11.3% of preterm births
Ben Nasr et al[8], 2009TunisiaAllSupportive care; antivenom use recommendedStableRisk of preterm birth, fetal anomalies, and long-term developmental issues
Kaplanoglu and Helvaci[6], 2015TurkeyAllSymptomatic care (no antivenom)StableAll live births
Leibenson et al[7], 2009Israel3rdSupportive careStableStillbirth
Brown et al[10], 2013ReviewAllSupportive care; antivenom for severe casesOptimal outcomes with early interventionImproved fetal outcomes with maternal stabilisation
Present case, 2025Kenya3rdEarly antivenom; multidisciplinary careFull recoveryHealthy neonate
Table 6 Key considerations in scorpion envenomation during pregnancy
Aspect
Clinical implications
PathophysiologyCatecholamine-induced uteroplacental vasoconstriction leading to fetal hypoxia
Maternal symptomsAutonomic storm (hypertension, tachycardia), local pain, potential for severe complications (eclampsia, myocarditis)
Fetal effectsTachycardia, distress, potential preterm labor or demise in severe cases
Critical managementPrompt antivenom administration, multidisciplinary care, and continuous fetal monitoring
Resource-limited challengesAntivenom accessibility, harmful traditional practices, and delayed presentation